Introduction
The Bcl-2 proto-oncogene encodes an inner mitochondrial membrane protein and is expressed in early lymphoid and myeloid progenitor cells. This protein was originally discovered by its translocation into the immunoglobulin locus in follicular B-cell lymphoma (Tsujimoto et al., 1986; Tsujimoto, 1989; Hockenbery et al., 1990) . Overexpression of Bcl-2 protein under the immunoglobulin promoter has been found to induce follicullar hyperplasia in transgenic mice. The product of Bcl-2 is known to play a role in promoting cell survival and inhibiting apoptosis following a variety of stimuli including g-radiation, glucocorticoid, hypothermia, growth factor withdrawal and chemotherapeutic agents (Vaux et al., 1988; Nunez et al., 1990; Miyashita et al., 1993; Ryan et al., 1994) . The apoptosissuppressing ability of Bcl-2 is antagonized by Bax, which is a member of the Bcl-2 family and promotes the cell death pathway. The ratios between these two proteins can determine cell survival following some stimuli (Oltvai et al., 1993) . Recent ®ndings demonstrate that Bcl-2 is able to inhibit apoptosis triggered by p53 (Chiou et al., 1994; Ryan et al., 1994) .
Tumor suppressor p53 plays a key role in the control of cell growth and its inactivation is a common event in human tumors . This protein is an important participant in the cellular responses to genotoxic stress including ionizing radiation (IR), multiple chemical DNA-damaging agents, and UV radiation (Clarke et al., 1993; Kastan et al., 1992; Zhan et al., 1994a Zhan et al., , 1996 . Both the protein level and transcriptional activity of p53 are increased by DNA damaging agents (Zhan et al., 1993) , and this protein is required for the activation of G1 arrest following exposure to DNA damage (Hartwell and Kastan, 1994) . p53 is a transcription factor and can regulate its downstream eector genes, such as GADD45 and p21
CIP/WAF1
, through the speci®c consensus sequence in intronic or promoter regions of these genes (El-Deiry et al., 1993; Kastan et al., 1992) . These p53-regulated genes are thought to have important functions in mediating p53's role as a tumor suppressor and growth regulator. Expression of p21 CIP1/WAF1 and GADD45 suppresses tumor cell growth (El-Deiry et al., 1993; Zhan et al., 1994c) and the inactivation of p21 CIP1/WAF1 has recently been found to be required for normal G1 checkpoint activation after IR (Deng et al., 1995) . p21
Cip1/Waf1 is a potent inhibitor of cyclin dependent kinases (Harper et al., 1993; Xiong et al., 1992) . In addition, both p21
Cip1/Waf1 and Gadd45 proteins have been found to bind to PCNA (Flores-Rozas et al., 1994; Smith et al., 1994) . It has previously been shown that p21 CIP1/WAF1 is induced following cellular exposure to genotoxic stresses, including IR, methylmethane sulfonate (MMS) and UV-radiation (Zhan et al., 1995) . The induction of p21 CIP1/WAF1 and GADD45 by IR is strictly dependent on normal cellular p53 function, while p53 has also been shown to exert a contributing role to induction of p21 CIP1/WAF1 and GADD45 by MMS and UV-radiation (Zhan et al., 1996) . BAX, which is a member of BCL-2 family, was found to be regulated by p53. Similar to p21 region of BAX gene (Miyashita and Reed, 1995) . Unlike p21 CIP1/WAF1 and GADD45, BAX induction by DNA damage requires that cells have both an apoptosis-susceptible phenotype and functional wildtype p53 (Zhan et al., 1994b) .
In addition to its well-known role in the control of cell cycle G1 arrest, p53 has been shown to be an important player in programmed cell death (apoptosis). Expression of p53 protein results in apoptosis in numerous human cell lines and Bcl-2 protein is able to block this p53-mediated apoptosis (Chiou et al., 1994; Clarke et al., 1993; Ryan et al., 1994) . It has been found that there is an inverse relationship between expression of wild-type p53 protein and expression of Bcl-2 protein in certain carcinomas (Haldar et al., 1994) . In mouse erythroleukemia DP16-1 cells, coexpression of c-myc and Bcl-2 is able to alter p53 nuclear localization and to suppress p53 function in controlling cell cycle (Ryan et al., 1994) . Coincident expression of Bcl-2 and p53 proteins in these cells has shown that Bcl-2 can relieve p53-mediated transcriptional repression (Shen and Shenk, 1994 ). In the current study, we report that expression of a high level of Bcl-2 protein in human Burkitt's lymphoma WMN cells inhibits the induction, as measured by increased mRNA levels, of p53-regulated genes including GADD45, p21
CIP1/WAF1 and BAX by IR and MMS. In agreement with the suppression of mRNA levels, Bcl-2 protein was shown to inhibit the p53-mediated transactivation of p21 CIP1/WAF1 and GADD45 promoter reporter constructs by DNA damaging agents including IR, MMS and UV-radiation. A similar observation was obtained with a typical p53 reporter construct PG13-CAT, which contains multiple p53 binding sites linked to a basal promoter. The results provide evidence for an inhibitory eect of Bcl-2 protein on p53-mediated cellular responses to genotoxic stress, suggesting that in order to achieve a strong transforming ability, Bcl-2 protein may also inhibit p53-mediated transactivation of p53-regulated genes.
Results

Inhibition of DNA damage-induced apoptosis by expression of Bcl-2 protein
To investigate the eect of Bcl-2 protein on the responses of p53-regulated genes to DNA damaging agents, the human Burkitt's lymphoma WMN cell line was infected with recombinant amphotrophic retrovirus carrying either G418 resistant gene(neo) alone or in tandem with BCL-2 cDNA. Previous studies have demonstrated that this line contains wide-type functional cellular p53 activity and is able to undergo p53-mediated apoptosis following g-irradiation (O'Connor et al., 1993; Zhan et al., 1994b) . After selection with G418, the level of Bcl-2 protein overexpression in infected cells was determined using Western blot analysis. As seen in Figure 1 , WMN-V cells, which were infected with a vector lacking BCL-2 cDNA insert, did not express detectable Bcl-2 protein. In contrast, substantial accumulation of Bcl-2 protein was observed in the cytoplasm and nucleus in two polyclonal sublines, which were infected with Bcl-2 retroviral expression vector (see Materials and methods) and designated` '. In the case of p53, the three lines exhibited similar increases in the level of p53 in the nuclear protein fraction following IR. No p53 protein was detected in the cytosol protein fraction, suggesting that expression of Bcl-2 protein alone can not alter the p53 nuclear localization and is unable to reduce the induction of p53 protein in the human Burkitt's lymphoma WMN cells.
As previously reported, WMN cells are capable of undergoing p53-mediated apoptosis after IR as measured by a DNA fragmentation assay (Zhan et al., 1994b) . To determine the eect of Bcl-2 protein on apoptosis of WMN cells treated with DNA-damaging agents, a sensitive and quantitative ®lter elution assay was employed. As shown in Figure 2a and b; an increased percentage of intracellular degraded DNA (`lysis fraction'), which represents DNA fragments of approximately 10 5 bp or less, and a decreased percentage of high molecular weight DNA (`high mw fraction') were observed at 6 h after WMN-V cells were treated with 12.6 Gy of IR. In contrast, WMN cells expressing a high level Bcl-2 protein showed no appreciable changes in either lysis fraction or high mw fraction even at 48 h following IR treatment. These results indicate that Bcl-2 protein is able to confer resistance to IR-induced apoptosis in WMN cells. Results were re¯ected by the increased survival of the WMN-Bcl-2b lines treated with IR (data not shown). Next examined was the eect of Bcl-2 protein on apoptosis induced by MMS, which is a DNA-base damaging agent and able to activate both p53-dependent and -independent pathways that may contribute to apoptosis. As shown in Figure 2c and d, WMN-V cells exhibited a rapid onset of apoptosis at 6 h after treatment with MMS, and apoptosis reached a maximum level 24 h after treatment. In contrast, WMN-Bcl-2b cells exhibited a delayed onset of apoptosis as well as a smaller magnitude of apoptosis. Thus, these results demonstrate that Bcl-2 protein is able to attenuate apoptosis induced by dierent types of DNA damaging agents. It has been widely accepted that the biological roles for p53 in the cellular response to genotoxic stress is at least in part mediated by its downstream genes such as p21
, GADD45 and BAX (El-Deiry et al., 1993; Zhan et al., 1994a,b) . Since Bcl-2 protein can block p53-mediated apoptosis, the eect of this protein on the activation of selected p53-regulated genes following exposure of cells to genotoxic stress was examined next. In Figure 3a , the induction of GADD45, p21 CIP1/WAF1 and BAX was determined in WMN-V and WMN-Bcl-2b lines after exposure to IR. Similar to our previous report (Zhan et al., 1994b) , the levels of transcripts for all three p53-regulated genes increased after IR, and peak induction occurred at 4 h. Interestingly, the IR induction of GADD45 was markedly reduced at all time points in the WMN-Bcl-2b cells (Figure 3a ), such that expression was no more than twofold that of untreated cells; a value of 1 indicates a transcript level equivalent to that of untreated cells. Similarly, suppressed IR induction of p21 CIP1/WAF1 was observed in the cells expressing Bcl-2 protein ( Figure 3a ). The suppression of p21/WAF1 induction was not as strong as that of GADD45. IR induction of BAX in the Bcl-2 expressing cells was evidently reduced at the 4 h timepoint ( Figure  2a ). Considering that the IR induction of GADD45, p21 CIP1/WAF1 and BAX are strictly dependent on normal cellular p53 function (Kastan et al., 1992; Zhan et al., 1994a Zhan et al., ,b, 1995 , we further investigated whether overexpression of Bcl-2 protein was capable of suppressing induction of those genes by MMS, which is able to induce GADD45 and p21 CIP1/WAF1 in a variety of human cell lines regardless of p53 status. As seen in Figure 3b , all three p53-regulated genes were induced by MMS treatment and overexpression of Bcl-2 protein appreciably inhibited induction of each gene. Interestingly, the induction of the c-FOS gene by IR and MMS was similar level in the WMN-V and WMN-Bcl-2b lines (Figure 3 ). It should be noted here that overexpression of Bcl-2 protein had no evident eect on the relative basal expression of GADD45, BAX and p21
. The relative level in untreated WMN-Bcl-2b cells varied less than twofold compared to WMN-V line. These results indicate that the mRNA induction of these three p53- 14 C-thymidine; after 24 h the cells were treated with 12.6 Gy or 50 mg/ml of MMS, harvested at the indicated times, and analysed by ®lter elution for DNA fragmentation (see Materials and methods). The fraction of DNA retained on the ®lter (designated`high mw'), the fraction of degraded intracellular DNA in the lysis fraction (designated`lysis'), and the fraction on extracellular DNA (designated`Extracellular') are shown. The values at the ordinate (0 hr) represent that of untreated cells, which were not substantially dierent from that of cells analysed immediately after treatment (O'Connor et al., 1991) regulated genes following DNA damage can be attenuated in the presence of Bcl-2 protein.
Bcl-2 protein modulates p53-mediated transactivation induced by DNA-damaging agents As discussed earlier, induction of GADD45, p21
and BAX following DNA damage can involve both p53-dependent and -independent pathways (Kastan et al., 1992; Michieli et al., 1994; Zhan et al., 1994a Zhan et al., ,b, 1995 . Both p53 protein levels and transcriptional activity can be induced by DNA damaging agents, such as IR, MMS, UV-irradiation and medium starvation (Zhan et al., 1993) . To investigate whether suppressed induction of p21 CIP1/WAF1
, BAX and GADD45 mRNA by Bcl-2 was due to the inhibition of p53-mediated transactivation, several experiments were conducted. As seen in Figure 4 , when the p53 reporter construct PG13-CAT was transfected into WMN-V cells and cells were treated with IR, MMS or UVradiation, a clear induction of CAT activity was observed. In contrast, the activation of PG13-CAT by IR, MMS and UV-radiation was signi®cantly lower in the WMN-Bcl-2b cells (CAT activity was reduced by approximately 70%). For comparative purpose, pC53-SN3, a wt p53 protein expression vector, was cotransfected with the PG13-CAT construct in both WMN-V and WMN-Bcl-2b cells. The results in Figure  4 demonstrate a clear inhibitory eect of Bcl-2 on p53-induced CAT activity in WMN-Bcl-2b cells. We further examined the suppressive eect of Bcl-2 on a WWp-CAT construct driven by the 2.3 Kb upstream promoter region of the human p21
. This promoter region contains two highly conserved p53-binding motifs which confer p53-speci®c inducibility. As seen in Figure 4 , treatment with MMS, UV or IR could activated the WWp-CAT construct (8.4-fold induction for MMS, 8.2-fold induction for UV and 7.6-fold induction for IR), and again expression of Bcl-2 protein resulted in an appreciable decrease in the induction of WWp-CAT by DNA-damaging agents. Therefore, expression of Bcl-2 is able to inhibit the induction of both a p53 reporter construct (PG13-CAT) and a CAT reporter construct driven by a p53-regulated promoter, which has p53 binding sites. Taken together, these results demonstrate that Bcl-2 protein is able to suppress the p53-mediated transactivation of its target genes following DNA damage.
As reported previously, the GADD45 promoter region does not contain a p53 binding motif and is not inducible by IR. GADD45 promoter CAT constructs can be induced by MMS or UV radiation in cells lacking functional p53. Interestingly, our recent ®ndings demonstrated that abrogation of p53 function resulted in reduced induction of GADD45 mRNA level and reduced activation of our GADD45 promoter CAT reporter construct (Zhan et al., 1996) . These results indicate that p53 still contributes to the responses of the GADD45 promoter to these non-IR stress probably through interaction with certain factors which can directly bind to the GADD45 promoter (Zhan et al., 1998) . For this reason, the eect of Bcl-2 protein on GADD45 promoter CAT construct (pHg45-CAT2) was also examined and results are shown in Figure 4 . Similar to our previous ®ndings, both MMS and UVradiation strongly induced CAT activity of the GADD45 promoter reporter construct in WMN-V cells, while the induction was signi®cantly reduced in the cells expressing Bcl-2. Therefore, Bcl-2 expression is also capable of suppressing activation of the GADD45 promoter by MMS and UV-radiation even though the GADD45 promoter does not contain a typical p53 binding site. Finally, a c-fos-CAT construct was included to rule out a nonspeci®c eect of Bcl-2 on cellular stress responsiveness. As shown in Figure 4 , the activation of the c-fos-CAT construct was similar in both WMN-V and WMN-Bcl-2b cells treated with MMS and UV-radiation. In addition, the inhibitory eects of Bcl-2 protein on p53 tansactivation have been observed by transiently cotransfecting Bcl-2 expression vector with WWp-CAT or pHg45-CAT2 constructs into WMN cells, which were then treated with MMS, UV-radiation and IR (data not shown). These results demonstrate that Bcl-2 protein can modulate the transcriptional activation of p53-regulated genes following DNA damage.
Discussion
In this report, we have found that Bcl-2 protein can inhibit p53-mediated transactivation in the human Burkitt's lymphoma WMN cell line. When high levels of Bcl-2 protein were achieved in WMN cells through retrovirus-mediated gene transfer, cells became markedly resistant to IR-induced apoptosis, which has previously been shown to be p53-dependent. This result was re¯ected by enhanced survival after IR in the Bcl-2 expressing cells, and is consistent with observations of others that expression of Bcl-2 can block p53-mediated apoptosis. We have also found that MMS-induced apoptosis is signi®cantly delayed and the magnitude reduced in cells expressing Bcl-2. Interestingly, the IR and MMS induction, as measured by increased mRNA levels, of GADD45, p21 CIP1/WAF1 and BAX were markedly reduced in WMN cells expressing Bcl-2 compared with that in WMN cells containing a control vector. Agreeing with these mRNA results, Bcl-2 protein was shown to suppress the activation of the p53 reporter construct PG13-CAT, the GADD45 promoter, and the p21 CIP1/WAF1 promoter CAT constructs following treatment with IR, MMS and UVradiation. These results demonstrate that in addition to its previously identi®ed inhibitory eect on apoptosis, Bcl-2 is able to inhibit DNA damage-induced transactivation of p53-regulated genes, which may function in multiple critical cellular responses including the control of cell cycle checkpoints, apoptosis and DNA repair.
The oncoprotein encoded by the Bcl-2 gene is well accepted for its ability to enhance cell survival and to inhibit apoptosis induced by many types of stimuli, including p53-mediated apoptosis (Chiou et al., 1994; Nunez et al., 1990; Ryan et al., 1994; Vaux et al., 1988) . The mechanism by which Bcl-2 protects cells from apoptosis may be that Bcl-2 protein can form heterodimers with Bax (and perhaps other related proteins), which is a member of Bcl-2 family and promotes apoptosis (Oltvai et al., 1993) . The consequence of this inhibition of apoptosis has been considered as an important cause for cell transformation and tumorigenesis. It has been reported by several groups that Bcl-2 can block IR-induced apoptosis (Ryan et al., 1994) . As expected, the inhibition of IRinduced apoptosis by Bcl-2 was also seen in the human Burkitt's lymphoma WMN cells with a high level of Bcl-2 protein. In addition, Bcl-2 protein was shown to inhibit apoptosis triggered by MMS, which is a DNAbase damaging agent and is able to induce apoptosis in cells lacking normal cellular p53 function, for example in H1299 cells (data not shown).
Consistent with its suppressive eect on the mRNA induction of p53-regulated genes by DNA damage (Figure 3 ), Bcl-2 protein was shown to inhibit p53-mediated transactivation. In Figure 4 , the activation of both PG13-CAT and WWp-CAT by IR were markedly reduced in the presence of Bcl-2. Since Bcl-2 had no eect on the activation of c-fos-CAT which was used as a control, Bcl-2 suppression on p53-mediated transactivation appears unlikely to be due to some nonspeci®c or general eect on stress signaling. In addition, this inhibitory eect was similar to that seen in the presence of p53 inhibitors, such as dominant-negative mutant p53 or HPVE6 (Zhan et al., 1996) . The explanation for reduced induction of the GADD45 promoter CAT construct by Bcl-2 is complex because MMS or UVradiation are able to activate this construct in cells regardless of normal p53 function (Zhan et al., 1996) . However, it has been recently reported that p53 can still exert its transactivating function in the responses of GADD45 promoter to these non-IR treatments probably through interaction with a second factor that can directly bind to the GADD45 promoter (Zhan et al., 1998) . Therefore, reduction of p53 transactivating capability by Bcl-2 protein may also lead to attenuated induction of the GADD45 promoter by MMS and UVradiation.
The precise mechanism for inhibition of p53-mediated transactivation by Bcl-2 requires further investigation. The results from the immuno-blot analysis did not show alterations of either p53 protein level or nuclear localization of p53 (Figure 1) . Therefore, Bcl-2 may not be able to routinely cause an exclusion of p53 from the nucleus. In a gel mobility shift assay, nuclear extracts isolated from WMN-Bcl-2b showed no signi®cant change in p53 binding to its consensus sequence compared with nuclear protein from WMN-V cells (data not shown). We also failed to supershift p53-bound DNA complex using anti-Bcl-2 antibodies (data not shown). However, p53 transactivation on its downstream genes is complex. The actual signal that triggers the DNA damage response for p53-regulated genes involves multiple factors and steps. Any change in the pathway may cause the alteration of induction of those genes. p53 is a nuclear phosphoprotein and its activation following DNA damage probably involves various post-translational modifications such as phosphorylation. Recent reports by several groups have shown p300/CBP, related transcriptional coactivators, are recruited in the p53-dependent signal pathway. Disruption of interaction between p300/CBP and p53 proteins counteracts p53-mediated G1 growth arrest and apoptosis (Avantaggiati et al., 1997; Gu et al., 1997; Lill et al., 1997) . Billon et al. (La Rocca et al., 1990) have also reported that p300 is required for p21 CIP1/WAF1 induction by NGF. Therefore, there is a possibility that Bcl-2 protein is able to interact with some coactivating molecules, which may be involved in the p53-mediated transactivation following DNA damage. Another possibility is that early events in apoptosis actually contribute to induction of p53-regulated genes and p53-transactivation activity, Bcl-2 may block these early events and thus attenuate the p53-response. Since p53 plays a important role in genotoxic-induced cellular responses, which are considered to be the critical biological events in the maintenance of genomic instability, the inhibitory eect of Bcl-2 on p53-mediated transactivation may well contribute to Bcl-2's role in cellular transformation and tumorigenesis.
Material and methods
Plasmid clones and probes
The following plasmid clones were used: pHulB2, a nearly full-length human GADD45 clone (Papathanasiou et al., 1991) ; N7p18, a human BAX cDNA clone (Oltvai et al., 1993) pZL-WAF1, a full-length human p21 CIP1/WAF1 clone (El-Deiry et al., 1993) . Dr Vogelstein has provided the following CAT reporter and expression constructs: WWp-CAT, which is a CAT reporter construct driven by p21/ WAF1 promoter (El-Deiry et al., 1993) and PG 13 -CAT, which contains 13 repeats of a p53 binding site inserted 5' to polyomavirus basal promoter linked to a CAT reporter gene (Kern et al., 1992) . pC53-SN3 is a construct expressing wt p53 protein (Baker et al., 1990) . c-fos-CAT was derived from a b-galactocidase reporter construct consisting of the c-fos gene where the reporter (followed by translation stop codons) was inserted into the ATG start site of c-fos (Robertson et al., 1995) ; in c-fos-CAT the reporter was replaced with the CAT open reading frame. The pHG45-CAT2 was constructed by inserting 7909 to +144 of the human GADD45 promoter into the promoterless CAT construct pCAT-Basic (Promega). The plasmid pZipBcl2, which is used for generation of defective recombinant retroviruses encoding the Bcl-2 protein, contains BCL-2 cDNA inserted into the BamHI site of pZipneoSV (Levine et al., 1993) . Finally, a 40-base pair oligonucleotide with antisense orientation to a portion of the ®rst translated exon of the c-fos gene was commercially provided by Oncogene Science.
Cells and cell treatment
The human Burkitt's lymphoma line WMN was grown in RPMI 1640 medium supplemented with 10% fetal bovine serum. Cells were irradiated with a 137 Cs source at 5.0 Gy/ min. For MMS treatment, cells were exposed in medium to methylmethane sulfonate (Aldrich) at 50 or 100 mg/ml for 4 h and then the medium was replaced with fresh medium. In the case of UV-irradiation, cells were washed with PBS once, resuspended in 15 ml of PBS in 100 mm plate and then irradiated with germicidal lamps at a dose rate from 2.1 J/m 2 to 14 J/m 2 . The original medium was replaced and cells were incubated at 378C for the indicated times.
Generation of helper-free retrovirus and infection of cells were performed as described previously (Woodworth et al., 1992) . Brie¯y, conditioned medium from producer cell lines was ®ltered, combined with WMN cells in suspension, and polyrene added to a ®nal concentration of 10 mg/ml. After 24 h, cells were centrifuged, washed three times with PBS, and cultured for 24 h in RPMI 1640 containing 10% fetal bovine serum. Non-infected cells were eliminated by maintaining cell cultures in the medium containing 500 mg/ ml G418 for 2 weeks. The clones designated`WMN-Bcl-2a' and`WMN-Bcl-2b', which expressed high levels of Bcl-2 protein, and`WMN-V', which only contained a control vector lacking the BCL-2 insert, were used for the following studies. These cell lines were not clonal but pooled populations.
Transfection of cells was performed by using Lipofectamine reagent according to the instruction of the manufacturer (Gibco ± BRL). Brie¯y, 5610 6 cells were grown in 6-well plates and transfected with 5 mg of indicated CAT reporter constructs; 16 h later, cells were changed to fresh medium, treated with DNA damaging-agents, and harvested for CAT analysis at 48 h after transfection.
CAT assay
Measurement of CAT activity was carried out as described previously (Zhan et al., 1993) . Brie¯y, cells were collected and resuspended in 0.25 M TRIS (pH 7.8). Cells were then disrupted by three freeze-thaw cycles, and equivalent amounts of protein were used for each assay. The CAT reaction mixture was incubated at 378 for 16 h and the CAT activity was determined by measuring the acetylation of 14 C-labeled chloramphenicol by thin-layer chromatography. Radioactivity was measured directly with Betascope model 630 blot analyzer (Betagen Inc.). The speci®c CAT activity was calculated by determining the fraction of chloramphenicol that had been acetylated. The relative CAT activity was determined by normalizing the activity of the treated samples to that of the untreated sample. Each value presented here was based on the average of at least three separate determinations.
RNA isolation and analysis
Cells were lysed in 4 M guanidine thiocyanate, and total cellular RNA was isolated by the Chomczynski method (Chomczynski and Sacchi, 1987) . Poly(A) + RNA was prepared as described previously (Hollander and Fornace, 1989) . For quantitative dot-blot analysis, 0.8 mg of poly(A) + RNA was directly blotted onto Nytran membranes at eight twofold dilutions for each sample. The blots were hybridized with cDNA probes as described previously (Hollander and Fornace, 1989 ) and scanned using a Betascope blot analyzer. At least four dot-blot determinations for each point were included in the analysis. Standard curves for control samples at various dilutions were generated using a computer program which then determined the relative increase for experimental samples Fornace, 1989, 1990) . The relative poly(A) + content of each RNA sample in the dot-blot analysis was estimated by using a labeled polythymidylic acid probe; this correction was small and usually varied by less than 25%. With this approach, the values for relative RNA are directly proportional to RNA abundance and dierences of 1.5-fold or greater could be reliably measured Fornace, 1989, 1990) ; results obtained with this sensitive approach agreed well with those obtained by RNAse protection determinations (Zhan et al., 1994a) .
Gel electrophoresis and immunoblot analysis
For measurement of Bcl-2 and p53 protein levels, total cellular protein was prepared as described previously (Zhan et al., 1993) . One hundred mg of the protein was loaded onto 12% SDS-polyacrylamide gels; following electrophoresis, the protein was transferred electrophoretically to Immobilon membranes (Millipore, Bedford, MA, USA). The membranes were then blocked for 30 min in 5% nonfat milk at room temperature. A monoclonal mouse antibody to Bcl-2 (4D7, Pharmingen, San Diego, USA) was used to measure Bcl-2 protein levels; for p53 detection, the membrane was probed with a monoclonal mouse antibody to p53 (pAb421b, Oncogene Science). Antibody reaction was determined with a chemiluminescence detection procedure according to the manufacturer's recommendation (Amersham).
DNA fragmentation assay
A modi®ed ®lter elution method was used for measuring DNA fragmentation as described previously (O'Connor et al., 1991) . Brie¯y, cells at 5610 5 ml 71 were incubated with 0.02 mCi ml
71
[methyl-
14 C] thymidine (New England Nuclear, Boston, MA, USA) overnight, the medium was replaced with nonradioactive medium, and the cells were incubated for an additional 4 h prior to treatment. After cells were treated with IR or MMS at the indicated times, cells were chilled on ice, ®ltered gently onto cold prewashed polycarbonate ®lters (Nuclepore Corporation, Pleasanton, CA, USA), and rinsed with cold buered saline. The medium and rinse were transferred into liquid scintillation vials (extracellular fraction). The washed cells were lysed in a 5 ml solution of 2% SDS and 0.5 mg/ml proteinas K at room temperature. Filters were then washed with 0.04 M EDTA. Lysis and EDTA fraction were combined and counted for radioactivity (lysis fraction). Filters were removed and heated for 1 h in 0.1 N HCl at 658C and 0.4 M NaOH was added before counting. Funnels were subsequently washed with 0.4 M NaOH, and radioactive counts on the funnels were added to the radioactive counts of the ®lter estimate of the amount of 14 C on the ®lters (high mw fraction)
